Drug resistance beyond extensively drugresistant tuberculosis: Individual patient data meta-analysis

Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB

研究成果: 雜誌貢獻文章同行評審

208 引文 斯高帕斯(Scopus)

摘要

The broadest pattern of tuberculosis (TB) drug resistance for which a consensus definition exists is extensively drug-resistant (XDR)-TB. It is not known if additional drug resistance portends worsened patient outcomes. This study compares treatment outcomes of XDR-TB patients with and without additional resistance in order to explore the need for a new definition. Individual patient data on XDR-TB outcomes were included in a meta-analysis comparing outcomes between XDR alone and three nonmutually exclusive XDR-TB patient groups: XDR plus resistance to all the second-line injectables (sli) and capreomycin and kanamycin/amikacin (XDR+2sli) XDR plus resistance to second-line injectables and to more than one group 4 drug, i.e. ethionamide/protionamide, cycloserine/ terizidone or para-aminosalicylic acid (XDR+sliG4) and XDR+sliG4 plus resistance to ethambutol and/or pyrazinamide (XDR+sliG4EZ). Of 405 XDR-TB cases, 301 were XDR alone, 68 XDR+2sli, 48 XDR+sliG4 and 42 XDR+sliG4EZ. In multivariate analysis, the odds of cure were significantly lower in XDR+2sli (adjusted OR 0.4, 95%CI 0.2- 0.8) compared to XDR alone, while odds of failure and death were higher in all XDR patients with additional resistance (adjusted OR 2.6-2.8). Patients with additional resistance beyond XDR-TB showed poorer outcomes. Limitations in availability, accuracy and reproducibility of current drug susceptibility testing methods preclude the adoption of a useful definition beyond the one currently used for XDR-TB.

原文英語
頁(從 - 到)169-179
頁數11
期刊European Respiratory Journal
42
發行號1
DOIs
出版狀態已發佈 - 7月 1 2013

ASJC Scopus subject areas

  • 肺和呼吸系統醫學

指紋

深入研究「Drug resistance beyond extensively drugresistant tuberculosis: Individual patient data meta-analysis」主題。共同形成了獨特的指紋。

引用此